MId-Day Losers From December 4: Kindred Biosciences, Barnes & Noble, Aeropostale

Kindred Biosciences Inc KIN -30% - Late Wednesday the company announced plans to stop its Atokin Study. Following the announcement Leerink Swann analysts downgraded the stock.

Christopher & Banks Corporation CBK -27% - Despite beating EPS estimates, the company reported that same-store sales were down 7.6 percent. In addition, the company offered weaker-than-expected guidance.

Aeropostale Inc ARO -26% - The company reported downbeat earnings and offered weak guidance. Moreover, Morgan Stanley analysts commented on the company saying “Aeropostale will never be debt free again.”

Barnes & Noble, Inc. BKS -6.7% -  Shares are lower following the company’s second-quarter results, missing EPS estimates by a large margin.

ANI Pharmaceuticals Inc ANIP -7.5% - The company announced a $100 million offering of convertible notes.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Intraday UpdateMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!